Health

Indian firm's AI blood test screens for 14 cancer types without a biopsy

· 1 source · Bihar edition

This story has no audio yet

Bengaluru-based Strand Life Sciences has developed CancerSpot, an AI-based blood test that looks for signs of 14 types of cancer in a single 20 ml blood sample. The cancers include those of the lung, liver, stomach, kidney, ovary, oesophagus, bladder, uterus, breast and prostate. Unlike a biopsy, which removes tissue from the affected part of the body and can be painful, the test needs no tissue sample.

The test was developed through a four-year study called EMERGE, which analysed blood samples from 1,480 people at 43 hospitals across the country, including cancer patients and healthy people. In independent testing, it identified 72 per cent of cancers, while the false-result rate was 1.4 per cent. The findings have been published in the Proceedings of the National Academy of Sciences, a US journal.

The technology is also meant to help spare healthy people from costly and complex tests. However, the test is only an initial screening and will not be treated as a final confirmation of cancer; further tests would be needed if required. It is expected to be introduced in almost all major hospitals in the country within one to two years.

Key points

  • Bengaluru-based Strand Life Sciences has developed CancerSpot, an AI-based test that checks a 20 ml blood sample for signs of 14 cancer types.
  • The test does not require removing tissue from the affected part of the body, unlike a biopsy.
  • In a four-year study of 1,480 people, the test identified 72 per cent of cancers in independent testing.
  • The false-result rate was reported as 1.4 per cent, and the findings were published in a US journal.
  • The test is an initial screening and its result will not be treated as a final confirmation of cancer.

Coverage from

This story was put together automatically from the sources above. Open a source to read its original report. How nuze makes stories